| | Business Summary | | Matritech,
Inc.
develops,
manufactures,
and
markets
cancer
diagnostic
products
based
on
its
proprietary
nuclear
matrix
protein
(NMP)
technology.
Using
its
proprietary
NMP
technology
and
expertise,
the
Company
has
developed
non-invasive
or
minimally
invasive
cancer
diagnostic
tests
for
bladder
and
cervical
cancer
and
is
developing
additional
tests
for
breast,
colon
and
prostate
cancer.
The
Company's
objective
is
to
develop
tests
that
will
be
more
accurate
than
existing
non-NMP
tests
and
will
result
in
lower
treatment
costs
and
a
higher
standard
of
patient
care
than
currently
available
tests.
The
Company's
first
product
based
on
its
NMP
technology,
the
NMP22
Test
Kit
for
bladder
cancer,
was
cleared
for
sale
in
the
United
States
by
the
U.S.
Food
and
Drug
Administration
as
a
prognostic
indicator
for
the
recurrence
of
bladder
cancer. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Matritech,
Inc.
develops,
manufactures
and
markets
cancer
diagnostic
products
based
on
its
proprietary
nuclear
matrix
protein
(NMP)
technology.
The
Company's
products
include
a
urine
assay
for
bladder
cancer
and
serum
assays
for
breast,
prostate
and
colorectal
cancers.
For
the
six
months
ended
6/01,
revenues
totaled
$1.2
million,
up
from
$330
thousand.
Net
loss
rose
76%
to
$4.5
million.
Results
reflect
acquisitions
and
higher
sales
in
the
U.S.,
offset
by
warrant
expenses. | | More
from
Market Guide: Significant
Developments |
| | | | FY1999
Compensation | | Pay | Exer | |
| Stephen Chubb, 56
Chairman
and CEO | $247K | -- | David Corbet, 46
Pres
and COO | 208K | -- | John Doherty, Jr., 52
VP-Fin.,
CFO, Treasurer, Sec. | -- | -- | Patrick Maley, 50
VP,
Sales and Marketing | 119K | -- | Ying-Jye Wu, Ph.D., 51
VP,
R&D | 157K | $22K | | Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/n/nmps.gif)